Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.50    -1.50 (-3.13%)
Bid:
46.00
Ask:
47.00
Spread: 1.00 (2.174%)
Market Cap: £42.63m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Contract Win & Trading Update

13 Aug 2007 07:00

Timestrip PLC13 August 2007 Timestrip plc (the 'Company') (AIM: TIME) Significant Contract Win and Trading Update The Company is a developer and manufacturer of unique label technologies. The Company is delighted to announce that it has signed a three year rollingcontract to supply the unique Timestrip technology to one of North America'sleading consumer product companies. The deal, estimated to be worth a minimum of US$3million in revenues to theCompany over the first three years, involves the integration of the Timestripinto a market leading product that is currently used in millions of homes acrossthe world. However, it is currently subject to confidentiality restrictionsrelating to the details of the product and the identity of the customer. This revenue estimate is based only on sales in North America, but theopportunity exists for significant additional revenues in the event that thetechnology is adopted by the customer on identical products that they currentlysell worldwide. This contract, which was referred to in the Company's recent preliminaryresults, is the first of several significant deals which are expected to besigned during the course of 2007. Sales cycles across large global multinationals are lengthy and it now seemslikely that the timing of these deals is such that they are not likely tocontribute materially to revenues in 2007. Accordingly, whilst the Companyexpects the revenue for the year to be above those of 2006, it now expects themto be lower than current market expectations for 2007. However, the dealsinvolve the integration of technology into established products lines and willtherefore have a recurring revenue impact into the longer term. The Company is pleased to report that it is experiencing unprecedented levels ofnew enquiries especially across the food and pharmaceutical sectors, which inturn is generating a strong sales pipeline. Interim results are expected towards the end of September at which timeShareholders will be provided with an update on the Company's continuedprogress. Enquiries: Paul Freedman/Reuben Isbitsky, Joint CEOs, Timestrip plc 01462 440 700 Shane Dolan, Biddicks 020 7448 1000 Fergus Marcroft, Evolution Securities 020 7071 4300 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Sep 20217:00 amRNS2021 Final Results
7th Sep 20217:00 amRNSNotice of Final Results and Investor Presentation
16th Jun 20217:00 amRNSYear-end Trading Update
10th Jun 20217:00 amRNSPermanent CEO Appointment & Investor Presentation
4th Jun 202111:30 amRNSHolding(s) in Company
4th Jun 202111:25 amRNSHolding(s) in Company
27th May 20215:29 pmRNSEmployee Benefit Trust Share Purchase
27th May 20217:00 amRNSExercise of Options
21st May 20217:00 amRNSUnapproved Share Option Scheme – Vesting of Awards
6th May 20217:00 amRNSNew Loan Accreditation & Financial Calendar Update
22nd Apr 20217:00 amRNSCorporate Update
9th Apr 20212:58 pmRNSEmployee Benefit Trust Share Purchase
26th Mar 20217:00 amRNSDirectorate Change
3rd Mar 20217:00 amRNSFurther re Directorate Change
19th Feb 202112:04 pmRNSDirectorate Changes
3rd Feb 20217:00 amRNSTechnology Infrastructure Update
19th Jan 20217:00 amRNSInterim Results
12th Jan 20217:00 amRNSHolding in Company
12th Jan 20217:00 amRNSHolding in Company
6th Jan 20217:00 amRNSDirectorate Changes
15th Dec 20205:15 pmRNSTR-1: Holding in Company - CORRECTION
9th Dec 20207:00 amRNSHalf Year Trading Update & Investor Presentation
1st Jun 20103:19 pmRNSResult of EGM
28th May 20107:00 amRNSUpdate
6th May 20108:37 amRNSStrategic Review - update
6th May 20107:01 amRNSNotice of EGM
6th May 20107:00 amRNSAppointment of adviser
4th May 201011:22 amRNSForm 8.3 - Timestrip PLC
4th May 20107:00 amRNSForm 8 (OPD) Timestrip
19th Apr 20107:30 amRNSStrategic Review Update and Suspension
19th Apr 20107:30 amRNSSuspension - Timestrip plc
24th Mar 20109:50 amRNSRule 8.1- (Timestrip)
19th Mar 201012:47 pmRNSStrategic Review - Update
18th Mar 20107:00 amRNSStrategic Review
5th Feb 20109:04 amRNSDirectorate Change
3rd Feb 20104:29 pmRNSAIM Rule 17
1st Feb 20107:00 amRNSContract Win - Toothbrush Order
5th Nov 200912:23 pmRNSUK Packaging Awards
28th Oct 20097:00 amRNSTimestrip IV - First full adoption by NHS Trust
26th Oct 20097:00 amRNSTimestrip Medical - 1st order in North America
14th Sep 20097:01 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNHS trials and appointment of distributor
24th Jul 20092:18 pmRNSResult of AGM
6th Jul 20097:00 amRNSNew distribution agreement
1st Jul 20097:00 amRNSPreliminary findings on Timestrip IV
29th Jun 20091:26 pmRNSNotice of AGM
11th Jun 20097:00 amRNSFinal Results
8th May 20097:00 amRNSIssue of Equity
5th May 20097:00 amRNSLuton & Dunstable Hospital orders TimestripIV
28th Apr 20097:00 amRNSTimestripIV showcased in NHS funded project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.